PhRMA

JANUARY 5, 2023

New research published in the American Journal of Managed Care (AJMC) underscores the critical role that medicines play in improving health and reducing disease complications and other, often costly, medical care and services. The study finds that since curative direct-acting antiviral medications for hepatitis C were approved in 2013, even after factoring in the cost of treatment, Medicaid has saved an estimated $15 billion in avoided health care costs and nearly 285,000 Medicaid enrollees are

211

211

Drug Topics

JANUARY 6, 2023

A local West Virginia mechanic exemplifies the kind of problem-solving that pharmacy executives from major chains should apply to their stores.

201

201

Pharmacy Times

JANUARY 3, 2023

In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.

Communication 171

Communication 171

STAT

JANUARY 4, 2023

Pregnancy, for the average person, is an exercise of extremes — swelling body, welling emotions, surging hormones. For people with chronic conditions and other disabilities, the experience can be even more jarring, full of additional barriers, stigma, and risks. But it’s not just pregnancy. In the United States, disabled people are less likely to be taught comprehensive sexual education and given access to contraceptives, and are more likely to have unintended pregnancies.

145

145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JANUARY 6, 2023

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients. The tool is an example of a large language model or LLM, which are designed to understand queries and generate text responses in plain language, drawing from large and complex datasets – in this case, medical research.

137

137

Drug Topics

JANUARY 4, 2023

The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.

201

201

STAT

JANUARY 4, 2023

Continuing economic uncertainty and the threat of a recession are casting a pall over health tech in 2023 — a dramatic shift for an industry that enjoyed abundant funding in the pandemic’s early stages. Last quarter’s string of layoffs at companies like Ro, Noom and ThirtyMadison portend tight budgets and conservative contracts this year, with employers unsure about which digital offerings actually drive down health care costs for workers.

FDA 144

FDA 144

Pharmaceutical Technology

JANUARY 6, 2023

While the treatment options for multiple sclerosis (MS) patients are growing each year with the approval of new agents, all of the currently marketed treatments only slow the disease’s progression and sometimes carry risks of severe side effects, such as liver failure or the development of viral infections. However, new mechanisms of action (MoAs) are in constant development, with some of the more innovative ones utilizing cell-based therapies.

115

115

Drug Topics

JANUARY 4, 2023

Reports of localized supply issues with Tamiflu have left some providers wondering how to best prioritize who gets the antiviral during a rough flu season.

187

187

Pharmacy Times

JANUARY 2, 2023

Pharmacists should educate patients about managing respiratory syncytial virus and let them know they may soon be able to get vaccinated.

Vaccines 149

Vaccines 149

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JANUARY 3, 2023

A diverse and inclusive workforce benefits science and research. But unless it includes people living with a disability — the largest minority group in the U.S. and around the world — research will never be fully representative and science will not reach its full potential. Although 27% of U.S. adults live with a disability, only 10% of science, engineering, and health doctorate holders, and less than 2% of researchers funded by the National Institutes of Health, report having a di

139

139

Fierce Healthcare

JANUARY 6, 2023

Carbon Health announces another round of layoffs, corporate restructuring amid challenging market conditions. hlandi. Fri, 01/06/2023 - 20:01.

128

128

Drug Topics

JANUARY 5, 2023

List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.

212

212

Pharmacy Times

JANUARY 3, 2023

Study finds a strong decline in hepatitis C incidence in the years immediately following broad access to direct-acting antiviral drugs.

149

149

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JANUARY 5, 2023

SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies to treat autoimmune diseases and cancer, is now planning to cut back on both jobs and experimental drugs after an early end to a deal with Janssen. The setback, announced Thursday, will cut the company’s size to 220 workers by the end of the first quarter of this year.

Immunization 125

Immunization 125

PharmaVoice

JANUARY 3, 2023

Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis.

111

111

Drug Topics

JANUARY 3, 2023

The CDC has reported an increase in drug overdose deaths from 2019 to 2022 in adolescents aged 10 to 19 years.

201

201

Pharmacy Times

JANUARY 4, 2023

The dual-action cell therapy is designed to eliminate established tumors, train the immune system to eradicate a primary tumor, and prevent recurrence.

Immunization 139

Immunization Vaccines 139

STAT

JANUARY 4, 2023

Walgreens plans to seek certification to begin providing abortion pills under new Food and Drug Administration rules that allow the drugs to be distributed by retail pharmacies, the company told STAT on Wednesday.  “We are working through the registration, necessary training of our pharmacists, as well as evaluating our pharmacy network in terms of where we normally dispense products that have extra FDA requirements and will dispense these consistent with federal and state laws,

FDA 114

FDA 114

Fierce Healthcare

JANUARY 5, 2023

Teladoc unveils new app integrating services for primary care and mental health, expands Spanish language offerings. hlandi. Thu, 01/05/2023 - 16:07.

123

123

Drug Topics

JANUARY 3, 2023

Keep your pharmacy services up to date with the latest 2023 ACIP vaccination schedule updates and recommendations.

Vaccines 200

Vaccines 200

Pharmacy Times

JANUARY 4, 2023

The FDA granted fidanacogene elaparvovec breakthrough, regenerative medicines advance therapy, and orphan drug designations.

FDA 152

FDA 152

pharmaphorum

JANUARY 6, 2023

The UK has formed an partnership with German biotech BioNTech to provide up to 10,000 patients with access to personalised cancer therapies, in another example of the country embracing the mRNA technologies that underpinned COVID-19 vaccines. The cancer immunotherapies will mainly be provided in the context of clinical trials over the alliance, which extends out to 2030, but also covers supply of commercial therapies if approved in the interim.

Vaccines 111

Vaccines Immunization 111

STAT

JANUARY 6, 2023

Now that the U.S. Food and Drug Administration has granted accelerated approval to the widely anticipated Alzheimer’s drug from Eisai and Biogen, a key question is the extent to which payers — private and public — will cover the treatment. Such decisions are based on myriad factors, starting with the average $26,500 price tag. But there are other considerations, including the quality of the clinical trial data, side effect concerns, the patient population for which the medic

FDA 107

FDA 107

Drug Topics

JANUARY 5, 2023

Patients with psoriasis seem to suffer more in the wintertime when flare-ups are much more common.

201

201

Pharmacy Times

JANUARY 6, 2023

Results show an association between linoleic acid, found in nuts, seeds, and vegetable oils, and increased hypersensitivity in psoriatic lesions.

139

139

Fierce Healthcare

JANUARY 5, 2023

Commonwealth Fund: Medicare inpatient spending concentrated among 2 systems in most regions. rking. Thu, 01/05/2023 - 15:07.

128

128

STAT

JANUARY 6, 2023

WASHINGTON — Members of Congress, state legislators, regulators, and legal advocates are calling on prisons to explain their poor hepatitis C treatment rates, after a STAT investigation revealing that more than 1,000 people had died from complications of the curable disease. In South Dakota and Oklahoma, lawmakers have written to their respective departments of corrections about STAT’s reporting.

105

105

Drug Topics

JANUARY 4, 2023

Research on last season’s influenza vaccine efficacy bodes well for patients who have gotten their flu shot this season.

Vaccines 187

Vaccines 187

Pharmacy Times

JANUARY 5, 2023

The protein, called suPAR, has long been known to be a biomarker for poor outcomes and disease progression in both kidney disease and cardiovascular disease.

Immunization 132

Immunization 132

Fierce Healthcare

JANUARY 5, 2023

How mental health made the 'remarkable transition' to virtual: study. fdiamond. Thu, 01/05/2023 - 15:21.

139

139

STAT

JANUARY 5, 2023

As 2023 begins, health care providers in the United States must make health records more easily available or risk losing Medicare funding under the 21st Century Cures Act. While this is a win for patients, providers, and researchers, the legislation’s failure to include dental care ignores the crucial link between oral health and overall health.

105

105

Drug Topics

JANUARY 5, 2023

Following certification, brick-and-mortar pharmacies will be able to provide the medication to patients.

FDA 187

FDA 187

Pharmacy Times

JANUARY 6, 2023

Ublituximab-xiiy from TG Therapeutics Inc is the first anti-CD20 monoclonal antibody approved for individuals with RMS that is administered as a 1-hour infusion after the starting dose.

FDA 123

FDA 123